An NPR member station
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

Neurontin

Snigdha Prakash reports on new documents showing that drug giant Parke Davis promoted the use of neurontin for pain treatment, even though it was not approved by the FDA for that use. Documents come from a trial underway in federal court in Boston.

Copyright 2002 NPR

Snigdha Prakash
Pieces by National Desk reporter Snigdha Prakash can be heard on NPR's All Things Considered and Morning Edition. The majority of Snigdha's past reports have focused on topics related to entrepreneurship, business, banking and the economy.